000 01389nam a2200373Ia 4500
001 EBC3050154
003 MiAaPQ
005 20240121042130.0
006 m o d |
007 cr cn|||||||||
008 040924s2003 sz gsb 000 0 fre d
020 _z9242209155
035 _a(MiAaPQ)EBC3050154
035 _a(Au-PeEL)EBL3050154
035 _a(CaPaEBR)ebr10062377
035 _a(CaONFJC)MIL8452
035 _a(OCoLC)927460498
040 _aMiAaPQ
_cMiAaPQ
_dMiAaPQ
050 4 _aRM316
_b.W49 2003
110 2 _aWHO Expert Committee on Drug Dependence.
245 1 0 _aComite OMS d'experts de la pharmacodependance
_h[electronic resource] :
_btrente-troisieme rapport.
260 _aGeneve :
_bOrganization mondiale de la Sante,
_c2003.
300 _av, 29 p.
490 1 _aOSM, serie de rapports techniques ;
_v915
504 _aIncludes bibliographical references.
533 _aElectronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.
650 0 _aDesigner drugs.
650 0 _aDrug abuse.
650 0 _aSubstance abuse.
655 4 _aElectronic books.
710 2 _aProQuest (Firm)
830 0 _aTechnical report series (World Health Organization) ;
_v915.
856 4 0 _uhttps://ebookcentral.proquest.com/lib/bacm-ebooks/detail.action?docID=3050154
_zClick to View
999 _c163309
_d163310